The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
12-Jul-10
$NA
Target:
Breast Care Business of Ethicon-Endo Surgery
Acquiror:
Devicor Medical Products, Inc. (a GTCR portfolio company)
Advised GTCR and Devicor Medical Products, Inc., a portfolio company of GTCR, on the acquisition of the Breast Care Business of Ethicon-Endo Surgery
28-Jun-10
$336 million
Target:
Scott Wilson Group plc
Acquiror:
URS Corporation
Advised Scott Wilson Group plc, a LSE listed global integrated design and engineering consultancy, on its sale to URS Corporation, a global provider of engineering, construction and technical services
14-Jun-10
$82 million
Target:
Bemis Company, Inc. (certain of its recently acquired packaging assets)
Acquiror:
Exopack Holding Company
Advised Bemis Company, Inc. on the sale of certain of its recently acquired flexible packaging assets as required by the US Department of Justice as a condition to the closing of its $1.2 billion acquisition of the Alcan Packaging Food Americas business (business unit of Rio Tinto plc)
10-Jun-10
$580 million
Target:
Tishman Speyer Washington D.C. Portfolio
Advised term loan and credit facility lenders to the Tishman Speyer partnership holding a portfolio of 28 office buildings in Washington D.C. and the surrounding area on a restructuring which resulted in payoff of the facilities in full
30-Apr-10
$NA
Target:
Pension Benefit Guaranty Corporation
Advised the Pension Benefit Guaranty Corporation ("PBGC") in connection with its claim in Lyondell’s Chapter 11 proceeding
26-Apr-10
$1.5 billion
Target:
Chloride Group plc
Acquiror:
Emerson Electric Co.
Advised Emerson Electric Co., a diversified global technology and industrial company, on its acquisition of Chloride Group plc, a manufacturer of uninterruptible power supply (UPS) systems
05-Apr-10
$225 million
Target:
Medegen, Inc
Acquiror:
CareFusion Corporation
Advised Medegen, Inc., a medical device company that develops, manufactures and markets clinically superior disposable intravenous therapy products on its sale to CareFusion, a global medical devices company
10-Mar-10
$576 million
Target:
Camelot Group plc
Acquiror:
Ontario Teachers’ Pensions Plan
Advised the shareholders of Camelot – Cadbury, De La Rue, Fujitsu, Royal Mail and Thales – on the sale of their shareholdings in Camelot, the operator of the UK National Lottery, to Ontario Teachers’ Pensions Plan
23-Feb-10
$NA
Target:
Heartscape Technologies, Inc.
Acquiror:
Roper Industries, Inc.
Advised Heartscape Technologies, a medical device company on its sale of substantially all its assets to Roper Industries, a diversified growth company
20-Dec-09
$1.3 billion
Target:
Mining Division of Terex Corp.
Acquiror:
Bucyrus International
Advised Bucyrus International, Inc., a global mining equipment manufacturer, on the acquisition of the mining division of Terex Corp., a diversified equipment company
09-Nov-09
$327 million
Target:
Enzon Pharmaceuticals, Inc.
Acquiror:
Sigma-Tau Pharmaceuticals
Advised Enzon Pharmaceuticals, Inc., a biopharmaceutical company on the sale of its specialty pharmaceutical business to Sigma-Tau, an Italian pharmaceutical company
27-Oct-09
$325 million
Target:
Fleetwood Enterprises, Inc.
Acquiror:
Various
Advised Fleetwood Enterprises, Inc. on the sale of substantially all of its assets, pursuant to multiple Section 363 sales
06-Oct-09
$1.2 billion
Target:
Avocent Corporation
Acquiror:
Emerson Electric Co.
Advised Emerson Electric Co., a diversified global technology and industrial company, on its acquisition of Avocent Corporation, a manufacturer of software and hardware products
06-Oct-09
$NA
Target:
Pension Benefit Guaranty Corporation
Advised the Pension Benefit Guaranty Corporation ("PBGC") on Delphi’s reorganization and the structure and terms of the PBGC’s recovery on account of Delphi’s pension plan termination
14-Aug-09
$724 million
Target:
NCI Building Systems, Inc.
Advised NCI Building Systems, Inc., one of North America’s largest integrated manufacturers and marketers of metal products for the non-residential construction industry, on its financial restructuring, which included a majority investment by CD&R and a restructuring of NCI’s outstanding debt
05-Jul-09
$1.2 billion
Target:
Alcan Packaging’s Food Americas business (business unit of Rio Tinto plc)
Acquiror:
Bemis Company, Inc.
Advised Bemis Company, Inc., a global supplier of flexible packaging and pressure sensitive materials, on its acquisition of Alcan Packaging’s Food Americas business
23-Jun-09
$155 million
Target:
Monogram Biosciences, Inc.
Acquiror:
Laboratory Corporation of America Holdings
Advised LabCorp on the acquisition of Monogram Biosciences, a molecular diagnostics company focused on guiding and improving the treatment of serious infectious diseases and cancer
04-May-09
$NA
Target:
Constar International Inc.
Advised Constar International Inc. in connection with its pre-arranged Chapter 11 proceedings
30-Apr-09
$NA
Target:
Chrysler LLC
Advised Chrysler in connection with the chapter 11 proceedings to effectuate the sale of substantially all of its operating assets and certain liabilities to a newly created entity that will be jointly owned by Fiat S.p.A., the VEBA Trust (responsible for the healthcare benefits of current and former employees of Chrysler), the US Treasury and the Canadian government
29-Apr-09
$NA
Target:
US Shipping Partners L.P.
Advised US Shipping Partners L.P. in connection with its pre-arranged Chapter 11 proceedings
12-Mar-09
$46.9 billion
Target:
Genentech, Inc.
Acquiror:
Roche Holding Ltd.
Advised Roche Holding Ltd., a world-leading provider of healthcare pharmaceuticals and diagnostics, on its acquisition of the outstanding publicly held interest in Genentech, Inc., a leading biotechnology company
09-Mar-09
$18.6 billion
Target:
Rohm & Haas Company
Acquiror:
The Dow Chemical Company
Advised The Dow Chemical Company during its negotiations pertaining to the Rohm & Haas settlement resolution
12-Oct-08
$6.0 billion
Target:
Hapag-Lloyd AG
Acquiror:
Albert Ballin KG
Advised TUI AG, Europe’s largest tourism company, on its sale of its shipping division Hapag-Lloyd AG, one of the leading global container shipping companies
08-Oct-08
$NA
Target:
MAN Ferrostaal AG
Acquiror:
International Petroleum Investment Company (IPIC)
Advised MAN AG in relation to its 70% sale of MAN Ferrostaal AG, a worldwide supplier of industrial services for the construction of large-scale industrial plants and machine supply, to International Petroleum Investment Company (IPIC)
01-Oct-08
$53 million
Target:
Biotage (Biosystems division)
Acquiror:
Qiagen NV
Advised Biotage AB (OMX: BIOT), a global biotechnology company, on its strategic review resulting in the disposal of its Biosystems division which offers systems for genetic analysis mainly for use in clinical research